Neuroscience stop selling you are getting cut.

anonymous

Guest
the show is over in a few months. Stop selling. Just go through the motions til layoffs or another job. Screw Kevin and his 10%. Go get another job, takeda has a neuroscience force and don't need more reps. Writing is on the wall.
 






























That's the word I'm hearing too. Deals off.
Nice try mark but the CEO of takeda was interviewed this am and they are looking at ways to do a mindful takeover as he called it.
This was this am and on reuters. Hearing things and hearing them from credible sources is another. So my source is Reuters what might yours be?
 




































Now is the time to crank up sales big time! When Takeda takes over, I will be one of the survivors due to my outstanding sales numbers. Go ahead and slack off and y'all will be filing for unemployment checques! I am going to to WIN and save my job! Good bye to the NBU whiners!!!
 






Now is the time to crank up sales big time! When Takeda takes over, I will be one of the survivors due to my outstanding sales numbers. Go ahead and slack off and y'all will be filing for unemployment checques! I am going to to WIN and save my job! Good bye to the NBU whiners!!!
Nope, not how it works. Takeda neuroscience team only has 1 drug in the bag. They won't keep any shire reps. But get that territory cookin for the next rep my little worker ant tool
 






Deal is a smokescreen to cover the upcoming loss of Amitiza and Uloric. Major cuts coming to Takeda. They have no pipeline and counting on molecules that are 3 plus years to market. PC will be gone and the USBU will be speciality only.
 






Nope, not how it works. Takeda neuroscience team only has 1 drug in the bag. They won't keep any shire reps. But get that territory cookin for the next rep my little worker ant tool

I think this is a serious potential bid for the following reasons: 1)
The Japanese Government will step in and help out with financing.
2) Japan is on a world wide spending/investment spree.
3) Japan is the #2 market for pharmaceuticals
4). Japan’s population is old... oldest avg. nation
5). FO, PS, MR are way in over their heads.. many investors have grown weary of them... the need to bail before they are canned.